The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Trills and Trat great posts
I've noticed @unicornpicker has picked up on Sensyne. So this seems suitable place to drop this as they have RNS out this morning:
MagnifEye Gains MHRA Approval
Lord (Paul) Drayson PhD FREng, CEO, said: "MagnifEye has demonstrated that it has the potential to play an important role in COVID-19 disease surveillance with increased lateral flow test reading accuracy and greater certainty over correct test interpretation. We believe our technology also demonstrates the value of AI in the analysis of medical images, a field that Sensyne has deep expertise in."
https://www.londonstockexchange.com/news-article/SENS/magnifeye-gains-mhra-approval/14967216
If we have an acceptance LFTs read by eye are not good enough due to limitations of human sight and possibilities for reading errors then that has to be a positive for Microtox BT.
Newuncle, don't know where you've got to with this (isn't the basic summary it is all good? Or better than that...) but I did find below Tweet from the good Doc interesting:
"@DocMoschos
Replying to
@DocMoschos
It is now down to the sensing / measuring platform companies to take our sample collector out there and start surveying people en masse for emission of the virus in their breath. We have @innovateuk #icure @Northern_Acc support to complete a small study on this. 4/n
1:06 pm · 6 May 2021·Twitter Web App"
https://twitter.com/DocMoschos/status/1390276727914569731
Not least because https://www.ukri.org/councils/innovate-uk/ have been mentioned a few times on here.
Just further indication of government interest...
"Launched in April 2018, UKRI is a non-departmental public body sponsored by the Department for Business, Energy and Industrial Strategy (BEIS)."
https://www.ukri.org/about-us/who-we-are/
Not really my area of expertise NU..........!
pretty sure we've licensed the design mind........ ;)
All the best (trillsg is ya man............ ! :)
Needs someone with a bigger brain than mine to analyse that report, it looks very complex.....Chesh you able to suggest anyone? Maybe T.Rat (aka Supt Hasting AC12) can do the in depth analysis required?
FF great find. Just unbelievable that DVRG still isn't being re-rated with so much going on, all positive here.
https://www.dropbox.com/s/e6160t7o5gzjuhw/PulmoBioMed%20Coronavirus%20-%20Public.pdf?dl=0#
"We can now confirm that our primary product, PBM-HALE, can efficiently capture aerosolised SARS-CoV-2 virus like particles with no loss of particle size or concentration. The device also works with liposomes and polymeric beads in the 100-200 nm size range.
Our CSO Dr Sterghios Moschos has updated the live scientific data file with PBM-HALE with new results on capture of SARS-CoV-2 virus like particles in aerosols. The data were independently generated by the Prof Jan Munch group (Inst. Virology) at University of Ulm, Germany. The results show no loss of virus particle size or concentration in the process.
Our clinical progress in completing the ongoing pilot study is also updated".